Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

behalf of the DAPS Investigators, on; Freemantle, N.; Satram-Hoang, S.; Tang, E.-T.; Kaur, P.; Macarios, D.; Siddhanti, S.; Borenstein, J.; L. Kendler, D.

doi:10.1007/s00198-011-1780-1

Public

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

Shared by NobleBlocks on Sep 16, 2011 • 12:00 AM UTC

Authors:

on behalf of the DAPS Investigators

Nick Freemantle

Sacha Satram‐Hoang

Abstract

UNLABELLED: The final analysis of this 2-year, randomized, crossover study showed that postmenopausal women with osteoporosis were more adherent, compliant, and persistent with subcutaneous denosumab injections every 6 months than with once-weekly alendronate tablets. After receiving both treatments...

Subject

Denosumab

Medicine

Osteoporosis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!